Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3).

Kaptein A, Jansen M, Dilaver G, Kitson J, Dash L, Wang E, Owen MJ, Bodmer JL, Tschopp J, Farrow SN.

FEBS Lett. 2000 Nov 24;485(2-3):135-41.

2.

TWEAK can induce cell death via endogenous TNF and TNF receptor 1.

Schneider P, Schwenzer R, Haas E, Mühlenbeck F, Schubert G, Scheurich P, Tschopp J, Wajant H.

Eur J Immunol. 1999 Jun;29(6):1785-92.

3.

Multiple pathways of TWEAK-induced cell death.

Nakayama M, Ishidoh K, Kayagaki N, Kojima Y, Yamaguchi N, Nakano H, Kominami E, Okumura K, Yagita H.

J Immunol. 2002 Jan 15;168(2):734-43.

4.

TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95).

Bodmer JL, Burns K, Schneider P, Hofmann K, Steiner V, Thome M, Bornand T, Hahne M, Schröter M, Becker K, Wilson A, French LE, Browning JL, MacDonald HR, Tschopp J.

Immunity. 1997 Jan;6(1):79-88.

5.
8.

Identification of a ligand for the death-domain-containing receptor Apo3.

Marsters SA, Sheridan JP, Pitti RM, Brush J, Goddard A, Ashkenazi A.

Curr Biol. 1998 Apr 23;8(9):525-8.

9.

Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells.

Harada N, Nakayama M, Nakano H, Fukuchi Y, Yagita H, Okumura K.

Biochem Biophys Res Commun. 2002 Dec 6;299(3):488-93.

PMID:
12445828
10.

Apparently normal tumor necrosis factor receptor 1 signaling in the absence of the silencer of death domains.

Endres R, Häcker G, Brosch I, Pfeffer K.

Mol Cell Biol. 2003 Sep;23(18):6609-17.

11.

TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells.

Wen L, Zhuang L, Luo X, Wei P.

J Biol Chem. 2003 Oct 3;278(40):39251-8.

12.

TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.

Wiley SR, Winkles JA.

Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):241-9. Review.

PMID:
12787562
13.
14.

TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis.

Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, Garcia I, Browning JL.

J Biol Chem. 1997 Dec 19;272(51):32401-10.

15.

TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF.

Xu H, Okamoto A, Ichikawa J, Ando T, Tasaka K, Masuyama K, Ogawa H, Yagita H, Okumura K, Nakao A.

Biochem Biophys Res Commun. 2004 May 28;318(2):422-7.

PMID:
15120617
16.

Functional expression of TWEAK in human colonic adenocarcinoma cells.

Kawakita T, Shiraki K, Yamanaka Y, Yamaguchi Y, Saitou Y, Enokimura N, Yamamoto N, Okano H, Sugimoto K, Murata K, Nakano T.

Int J Oncol. 2005 Jan;26(1):87-93.

PMID:
15586228
17.

Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice.

Muñoz-García B, Moreno JA, López-Franco O, Sanz AB, Martín-Ventura JL, Blanco J, Jakubowski A, Burkly LC, Ortiz A, Egido J, Blanco-Colio LM.

Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2061-8. doi: 10.1161/ATVBAHA.109.194852.

18.
19.

Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death.

Nakayama M, Ishidoh K, Kojima Y, Harada N, Kominami E, Okumura K, Yagita H.

J Immunol. 2003 Jan 1;170(1):341-8.

Items per page

Supplemental Content

Support Center